G. Daniel Schachter, MD, FRCPC, DABD

Research Toronto
29 Park Road
Toronto, Ontario, Canada
M4W 2N2
416-962-0123


Specialty: Dermatology

 

Research Interests: Acne, Actinic Keratosis, Atopic Dermatitis, Onychomycosis, Psoriasis, Psoriatic Arthritis, Rosacea

Dr. G. Daniel Schachter is an accomplished dermatologist and a Principal Investigator of uncommon focus and dedication.  A graduate of the University of Toronto’s selective M.D. program, Dr. Schachter has maintained close ties with the Greater Toronto Area while earning a reputation as a leading figure in the study and treatment of skin disease.  With over 40 years’ clinical experience and 30 years of research credentials, Dr. Schachter is highly respected among the academic community, the clinical research sector, and the general public.

Specializing in leading edge Psoriasis, Acne, Warts, Lichen Planus, Dermatitis and Skin Cancer treatments, Dr. Schachter has investigated potential therapeutics for Psoriasis, Psoriatic Arthritis, Onychomycosis, Rosacea, Acne, Subcutaneous Submental Fat Reduction, Dermal Fillers, Facial Rhytides (Nasolabial Folds), and Age-Related Skin Changes. 

Dr. Schachter is driven to produce reliable study data and exceed his patients’ expectations.  A consummate professional, he remains committed to continuous development through CME programs and an active role as Lecturer in the University of Toronto’s Dermatology department.

Serving on a number of Advisory Boards and Expert Panels, Dr. Schachter’s expertise in all stages of pharmaceutical research and development is a guarantee of superior clinical investigation.

 

Click to view Dr. Daniel Schachter's Publications


Schachter D, Bertucci V, Solish N. Calcium hydroxylapatite with integral lidocaine provides improved pain control for the correction of nasolabial folds. J Drugs Dermatol 2016 Aug 1; 15(8): 1005-10. PMID: 27538003

Smith KC, Schachter GD. YSGG 2790-nm superficial ablative and fractional ablative laser treatment. Facial Plast Surg Clin North Am 2011 May; 19(2):253-60. PMID: 21763987 / doi: 10.1016/j.fsc.2011.05.005

Smith KC, Schachter GD. Technical characteristics of fractional light devices. Facial Plast Surg Clin North Am 2011 May; 19(2):235-40. PMID: 21763984 / doi: 10.1016/j.fsc.2011.05.003

Carruthers A, Carey W, De Lorenzi C, Remington K, Schachter D, Sapra S. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, restylane perlane and hylaform, in the treatment of nasolabial folds. Dermatol Surg 2005 Nov; 31(11 Pt 2):1591-8. PMID: 16416643

Harris DM, Fried D, Reinisch L, Bell T, Schachter D, From L, Burkart J.  Eyelid resurfacing.  Lasers Surg Med 1999; 25(2):107-122 & Erratum in Lasers Surg Med 2000; 26(4):415.  PMID: 10455216

Bell T, Harris DM, Schachter D, Burkart J.  100 ?sec pulsed CO2 laser resurfacing of lower eyelids: erythema and rhytides reduction.  Proc SPIE 1997; 2970:360-366.  doi:10.1117/12.275066

Harris DM, Bell T, From L, Schachter D.  Facial skin resurfacing with a very short-pulsed CO2 laser: beam characterization and initial histological results.  Proc SPIE 1996; 2671: 324-328.  doi:10.1117/12.240010

Schachter GD.  Acne management.  Dermatology Times of Canada.

Ho V, Cloutier R, Gulliver W, Lauzon G, Marcoux D, Miller R, Murray E, Schachter GD.  Acne assessment and treatment algorithm: report of an acne workshop.  J Cutan Med Surg 1996; 1 Suppl 3.

Ho V, Schachter GD, et al.  Acne management for the 90’s: current treatment guidelines.  Can J Diagnosis; Suppl: 5-25.

Maddin WS, Schachter GD.  Open, non-comparative evaluation of topical metronidazole in the treatment of moderate to severe rosacea.  Can J Dermatol 1995 Jan/Feb; 7(1):740-744.

Klinkhoff AV, Gertner E, Chalmers A, Gladman DD, Stewart WD, Schachter GD, Schachter RK.  Pilot study of etretinate in psoriatic arthritis.  J Rheumatol 1989 Jun; 16(6):789-791.  PMID: 2778761

Lester RS, Schachter GD, Light MJ.  Isotretinoin and tetracycline in the management of severe nodulocystic acne.  Int J Dermatol 1985 May; 24(4):252-257.  PMID: 3159698

Copyright 2014 Probity Medical Research Inc. All Rights Reserved.

Login